JP Morgan
Top Five Articles on 360Dx Last Week: Quest Diagnostics, Lucid Diagnostics, JPM Healthcare; More
Last week, readers were most interested in Quest Diagnostics and other company presentations at the JP Morgan Healthcare Conference, as well as layoffs at Lucid Diagnostics.
Top Five Articles on 360Dx Last Week: JP Morgan Healthcare Conference; Quest Update; and More
Last week, readers were most interested in updates provided by Labcorp, Abbott, and others at the JP Morgan Healthcare Conference.
Quanterix Restructuring Efforts on Track, CEO Says at JP Morgan Conference
The restructuring is to scale its operations and assays to better meet both current and anticipated demand for higher-throughput testing, its CEO said.
JP Morgan Healthcare Conference, Day 3: Invitae, Bio-Rad, Bio-Techne, Opko
On the penultimate day of the conference, Invitae provided color on its recent decisions to pull out of certain businesses, while Bio-Rad talked about its clinical plans.
Among potential growth opportunities, the firm's new CEO noted hospital lab M&A and STD and cancer testing.